× NICE uses cookies to make the site better.  Learn more
A-Z
Topics
Latest

Skin conditions

About

What is covered

This interactive flowchart covers the guidance and advice that NICE has produced on skin conditions.
For more information about skin conditions, including evidence from NICE-accredited sources, visit NICE Evidence Search.

Updates

Updates to this interactive flowchart

21 June 2016 Adalimumab for treating moderate to severe hidradenitis suppurativa (NICE technology appraisal guidance 392) added to hidradenitis suppurativa.
8 June 2015 Omalizumab for previously treated chronic spontaneous urticaria (NICE technology appraisal guidance 339) added to inflammatory skin conditions and reactions, including urticaria.

Person-centred care

People have the right to be involved in discussions and make informed decisions about their care, as described in your care.
Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding.

Your responsibility

Guidelines

The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian.
Local commissioners and providers of healthcare have a responsibility to enable the guideline to be applied when individual professionals and people using services wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.

Technology appraisals

The recommendations in this interactive flowchart represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take these recommendations fully into account, alongside the individual needs, preferences and values of their patients. The application of the recommendations in this interactive flowchart is at the discretion of health professionals and their individual patients and do not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Commissioners and/or providers have a responsibility to provide the funding required to enable the recommendations to be applied when individual health professionals and their patients wish to use it, in accordance with the NHS Constitution. They should do so in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.

Medical technologies guidance, diagnostics guidance and interventional procedures guidance

The recommendations in this interactive flowchart represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take these recommendations fully into account. However, the interactive flowchart does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.
Commissioners and/or providers have a responsibility to implement the recommendations, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this interactive flowchart should be interpreted in a way that would be inconsistent with compliance with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.

Short Text

Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart

What is covered

This interactive flowchart covers the guidance and advice that NICE has produced on skin conditions.
For more information about skin conditions, including evidence from NICE-accredited sources, visit NICE Evidence Search.

Updates

Updates to this interactive flowchart

21 June 2016 Adalimumab for treating moderate to severe hidradenitis suppurativa (NICE technology appraisal guidance 392) added to hidradenitis suppurativa.
8 June 2015 Omalizumab for previously treated chronic spontaneous urticaria (NICE technology appraisal guidance 339) added to inflammatory skin conditions and reactions, including urticaria.

Sources

NICE guidance and other sources used to create this interactive flowchart.
Adalimumab for treating moderate to severe hidradenitis suppurativa (2016) NICE technology appraisal guidance 392
Omalizumab for previously treated chronic spontaneous urticaria (2015) NICE technology appraisal guidance 339
Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limb (2014) NICE interventional procedures guidance 487
Negative pressure wound therapy for the open abdomen (2013) NICE interventional procedures guidance 467
Intralesional photocoagulation of subcutaneous congenital vascular disorders (2004) NICE interventional procedures guidance 90
The MIST Therapy system for the promotion of wound healing (2011) NICE medical technologies guidance 5
Hyperhidrosis: oxybutynin (2017) NICE evidence summary 10
Facial erythema of rosacea: brimonidine tartrate gel (2014) NICE evidence summary ESNM43
Actinic keratosis: ingenol mebutate gel (2013) NICE evidence summary ESNM14
Infantile haemangioma: topical timolol (2015) NICE evidence summary ESUOM47
Digital ulcers: sildenafil (2015) NICE evidence summary ESUOM42
Scleroderma: oral mycophenolate (2014) NICE evidence summary ESUOM32
Chronic urticaria: off-label doses of cetirizine (2014) NICE evidence summary ESUOM31
Difficult-to-treat scabies: oral ivermectin (2014) NICE evidence summary ESUOM29
Hyperhidrosis: oral glycopyrronium bromide (2013) NICE evidence summary ESUOM16
TopClosure Tension Relief System for wound closure (2017) NICE medtech innovation briefing 97
UrgoStart for chronic wounds (2016) NICE medtech innovation briefing 82

Quality standards

Quality statements

Effective interventions library

Effective interventions library

Successful effective interventions library details

Implementation

Information for the public

NICE has written information for the public on each of the following topics.

Pathway information

Person-centred care

People have the right to be involved in discussions and make informed decisions about their care, as described in your care.
Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding.

Your responsibility

Guidelines

The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian.
Local commissioners and providers of healthcare have a responsibility to enable the guideline to be applied when individual professionals and people using services wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.

Technology appraisals

The recommendations in this interactive flowchart represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take these recommendations fully into account, alongside the individual needs, preferences and values of their patients. The application of the recommendations in this interactive flowchart is at the discretion of health professionals and their individual patients and do not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Commissioners and/or providers have a responsibility to provide the funding required to enable the recommendations to be applied when individual health professionals and their patients wish to use it, in accordance with the NHS Constitution. They should do so in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.

Medical technologies guidance, diagnostics guidance and interventional procedures guidance

The recommendations in this interactive flowchart represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take these recommendations fully into account. However, the interactive flowchart does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.
Commissioners and/or providers have a responsibility to implement the recommendations, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this interactive flowchart should be interpreted in a way that would be inconsistent with compliance with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.

Supporting information

Glossary

Paths in this pathway

Pathway created: March 2015 Last updated: September 2017

© NICE 2017. All rights reserved. Subject to Notice of rights.

Recently viewed